Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Lupaka Gold Corp | LQPA | Apr 16, 2025 | 0.02 | 0.00 |
Luxbright | LUR | Apr 16, 2025 | 0.06 | 0.00 |
Luxfer Holdings PLC Ordinary Shares | LX4A | Apr 16, 2025 | 9.00 | 0.00 |
Luxxfolio Holdings | LUH0 | Apr 16, 2025 | 0.09 | 0.00 |
Luxxfolio Holdings Inc | LUH | Apr 16, 2025 | 0.00 | 0.00 |
Luye Pharma Group Ltd | LUP | Apr 16, 2025 | 0.20 | 0.00 |
LUZHOU XINGLU WATER H YC1 | 2LX | Apr 16, 2025 | 0.06 | 0.00 |
Lvmh Moet Hennessy Vuitton SE | MOH | Apr 16, 2025 | 481.70 | 0.00 |
Lvmh Moet Hennessy Vuitton SE | MOHF | Apr 16, 2025 | 95.80 | 0.00 |
Lyckegard Group AB | F55 | Apr 16, 2025 | 0.15 | 0.00 |
LYCOPODIUM LTD. | LW1 | Apr 16, 2025 | 5.85 | 0.00 |
LYCOS ENERGY INC. NEW | G4P0 | Apr 16, 2025 | 1.06 | 0.00 |
Lyft, Inc. - Class A | LY0 | Apr 16, 2025 | 9.57 | 0.00 |
Lynas Rare Earths Limited | LYI | Apr 16, 2025 | 4.60 | 0.00 |
Lynas Rare Earths Limited American Depositary Receipts - Spo | LYIC | Apr 16, 2025 | 4.48 | 0.00 |
LyondellBasell Industries NV Ordinary Shares Class A (Nether | DLY | Apr 16, 2025 | 50.18 | 0.00 |
Lytix Biopharma | 6BG | Apr 16, 2025 | 0.40 | 0.00 |
L`Oreal | LORA | Apr 16, 2025 | 66.50 | 0.00 |
M Vest Water | 7YA | Apr 16, 2025 | 0.84 | 0.00 |
M&C Saatchi | IZH | Apr 16, 2025 | 1.82 | 0.00 |
M&G | 7MP | Apr 16, 2025 | 2.29 | 0.00 |
M&T Bank Corporation | MTZ | Apr 16, 2025 | 138.70 | 0.00 |
M.P. Evans Group Plc | NYP | Apr 16, 2025 | 11.30 | 0.00 |
M/I Homes, Inc. | 4MI | Apr 16, 2025 | 93.82 | 0.00 |
M1 Kliniken AG | M12 | Apr 16, 2025 | 15.44 | 0.00 |
M3, Inc. | 4YC | Apr 16, 2025 | 10.50 | 0.00 |
MAANSHAN IRON | YM9A | Apr 16, 2025 | 0.19 | 0.00 |
Maat Pharma S.A. | 4RD | Apr 16, 2025 | 6.04 | 0.00 |
Mabion S.A. | 272 | Apr 16, 2025 | 2.38 | 0.00 |
Mabuchi Motor Co. Ltd. | V94 | Apr 16, 2025 | 12.30 | 0.00 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.